Audited Results of Orchid Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	811.33	921.93	819.37	665.90	556.97
Manufacturing Expenses	0	64.98	62.92	61.26	52.74
Personnel Expenses	88.14	86.36	69.64	65.35	60.21
Selling Expenses	0	0.03	0.03	0.04	0.04
Administrative Expenses	151.98	83.41	77.70	58.45	59.93
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	765.99	798.40	708.69	582.28	499.72
Operating Profit	45.34	123.53	110.68	83.62	57.26
Other Recurring Income	55.24	31.93	30.39	19.43	9
Adjusted PBDIT	100.58	155.46	141.07	103.05	66.26
Financial Expenses	13.24	14.54	16.33	32.23	87.02
Depreciation	35.56	34.44	33.22	54.79	32.01
Other Write offs	0	0	0	0	0
Adjusted PBT	51.78	106.48	91.52	16.04	-52.77
Tax Charges	0	0	-3.23	0	0
Adjusted PAT	51.78	106.48	94.75	16.04	-52.77
Non Recurring Items	-6.57	0	0	38.15	47.96
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	45.21	106.48	94.75	54.19	-4.81
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	45.21	-1,881.90	-1,987.93	-2,082.45	-2,138.10

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article